Key Financial Data Of Reporting Company

TAKARA BIO INC. - Filing #7256073

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
45,039,000,000 JPY
25,354,000,000 JPY
27,043,000,000 JPY
43,505,000,000 JPY
57,280,000,000 JPY
78,142,000,000 JPY
50,398,000,000 JPY
67,699,000,000 JPY
33,885,000,000 JPY
46,086,000,000 JPY
Ordinary profit (loss)
2,592,000,000 JPY
453,000,000 JPY
3,853,000,000 JPY
3,405,000,000 JPY
17,444,000,000 JPY
20,682,000,000 JPY
25,063,000,000 JPY
28,459,000,000 JPY
11,495,000,000 JPY
14,159,000,000 JPY
Profit (loss)
209,000,000 JPY
2,899,000,000 JPY
14,313,000,000 JPY
18,485,000,000 JPY
8,681,000,000 JPY
Share capital
14,965,000,000 JPY
14,965,000,000 JPY
14,965,000,000 JPY
14,965,000,000 JPY
14,965,000,000 JPY
Total number of issued shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
120,415,600 xbrli:shares
Net assets
115,849,000,000 JPY
92,548,000,000 JPY
111,784,000,000 JPY
94,385,000,000 JPY
96,544,000,000 JPY
112,454,000,000 JPY
96,064,000,000 JPY
86,204,000,000 JPY
74,302,000,000 JPY
69,645,000,000 JPY
Total assets
125,334,000,000 JPY
97,864,000,000 JPY
121,252,000,000 JPY
100,320,000,000 JPY
108,607,000,000 JPY
129,202,000,000 JPY
115,712,000,000 JPY
101,386,000,000 JPY
89,750,000,000 JPY
81,124,000,000 JPY
Net assets per share
959.19
768.57
926.00
783.83
801.76
931.93
796.18
715.89
616.05
578.38
Dividend paid per share
17.00
17.00
42.00
33.00
16.00
Interim dividend paid per share
Basic earnings (loss) per share
8.65
1.74
24.08
12.30
118.87
132.97
153.51
164.84
72.10
79.29
Diluted earnings per share
Equity-to-asset ratio
0.922 xbrli:pure
0.946 xbrli:pure
0.920 xbrli:pure
0.941 xbrli:pure
0.889 xbrli:pure
0.869 xbrli:pure
0.829 xbrli:pure
0.850 xbrli:pure
0.827 xbrli:pure
0.859 xbrli:pure
Rate of return on equity
0.0092 xbrli:pure
0.0022 xbrli:pure
0.0304 xbrli:pure
0.0132 xbrli:pure
0.1566 xbrli:pure
0.1539 xbrli:pure
0.2372 xbrli:pure
0.2335 xbrli:pure
0.1320 xbrli:pure
0.1357 xbrli:pure
Price-earnings ratio
95.69 xbrli:pure
475.88 xbrli:pure
40.29 xbrli:pure
78.87 xbrli:pure
14.58 xbrli:pure
13.03 xbrli:pure
14.60 xbrli:pure
13.59 xbrli:pure
41.17 xbrli:pure
37.43 xbrli:pure
Payout ratio
9.770 xbrli:pure
0.706 xbrli:pure
0.353 xbrli:pure
0.215 xbrli:pure
0.222 xbrli:pure
Net cash provided by (used in) operating activities
5,844,000,000 JPY
1,711,000,000 JPY
36,897,000,000 JPY
6,985,000,000 JPY
13,943,000,000 JPY
Net cash provided by (used in) investing activities
-10,912,000,000 JPY
-13,043,000,000 JPY
-6,693,000,000 JPY
-7,071,000,000 JPY
-3,778,000,000 JPY
Net cash provided by (used in) financing activities
-2,256,000,000 JPY
-5,233,000,000 JPY
-4,119,000,000 JPY
-2,070,000,000 JPY
-1,103,000,000 JPY
Cash and cash equivalents
27,036,000,000 JPY
33,171,000,000 JPY
49,058,000,000 JPY
22,160,000,000 JPY
23,308,000,000 JPY
Number of employees
1,779 xbrli:pure
762 xbrli:pure
1,838 xbrli:pure
802 xbrli:pure
769 xbrli:pure
1,793 xbrli:pure
1,666 xbrli:pure
669 xbrli:pure
1,539 xbrli:pure
570 xbrli:pure
Total shareholder return
0.427 xbrli:pure
0.483 xbrli:pure
0.818 xbrli:pure
1.026 xbrli:pure
1.338 xbrli:pure
Total return on share price index
2.134 xbrli:pure
2.168 xbrli:pure
1.534 xbrli:pure
1.450 xbrli:pure
1.421 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.